Pharmacelera

The company develops proprietary Computer-Aided Drug Design (CADD) software, including PharmScreen and exaScreen, which utilize quantum mechanics algorithms and machine learning to explore large chemical spaces. These tools assist in target identification, hit-to-lead, and lead optimization by predicting ligand binding properties and identifying novel chemical compounds. Their services and software are designed for small biotech companies, large pharmaceutical R&D departments, and public research institutions.